Clinical Trials List
Protocol NumberDMD114349
Not yet recruiting
2011-10-01 - 2015-03-31
Phase III
Terminated1
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
200 participants
